BioMarin Pharmaceutical Inc.
Cash Flow Statement
| Line Item | FY2009 | FY2008 |
|---|---|---|
| Operating Activities | ||
| Net Income | $-488.0K | $30.8M |
| Depreciation & Amortization | $21.0M | $17.6M |
| Depreciation | $15.9M | — |
| Amortization | — | — |
| Stock-Based Compensation | $36.0M | $28.3M |
| Net Cash from Operating Activities | $87.7M | $-9.2M |
| Investing Activities | ||
| Capital Expenditures | $89.8M | $56.4M |
| Business Acquisitions | $17.5M | $0 |
| Net Cash from Investing Activities | $-79.7M | $-19.1M |
| Financing Activities | ||
| Dividends Paid | — | — |
| Stock Repurchases | — | — |
| Net Cash from Financing Activities | $-63.8M | $22.8M |
| Net Change in Cash | $-55.7M | $-5.4M |
| Free Cash Flow | $-2.1M | $-65.5M |